Schedule 13G ownership disclosure

Vor BioPharma Inc

Common Stock, $0.0001 par value per share · CUSIP: 929033207

Event date: 2025-12-31

Filing-level shares
4,297,464.00
Percent of class
9.9%
  • Verve Capital Limited

    Shares: 4,297,464.00 · Class: 9.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0002088344-26-000003
Form type
SCHEDULE 13G/A
Filer
Verve Capital Ltd
CIK
CIK 2088344
Filed
Feb 17, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub